# FDA Approves Rare Brain Disease Treatment Trial for NeuroSense
NeuroSense Therapeutics gains FDA approval for PrimeC, a promising ALS treatment, paving the way for clinical trials and commercial release.
NeuroSense Therapeutics gains FDA approval for PrimeC, a promising ALS treatment, paving the way for clinical trials and commercial release.